Moreover, GW-7647 recapitulated the alterations in the glycolytic phenotype, speaking in favor of a crucial role for PPAR-α in effecting the ATGL/FAs signaling driving the metabolic rewiring of HCC cell lines. The gene discussed is PNPLA2; the disease is hepatocellular carcinoma.